Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Porter

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
The Journal of Rheumatology|March 16, 2021
Secukinumab Efficacy on Enthesitis in Patients With Ankylosing Spondylitis: Pooled Analysis of Four Pivotal Phase III StudiesGeorg Schett, Xenofon Baraliakos, Filip Van den Bosch, et al.
ACR Open Rheumatology|May 1, 2020
Incidence of Uveitis in Secukinumab-treated Patients With Ankylosing Spondylitis: Pooled Data Analysis From Three Phase 3 StudiesAtul A Deodhar, Corine Miceli-Richard, Xenofon Baraliakos, et al.
Rheumatology (Oxford, England)|June 9, 2025
Automated detection of spinal bone marrow oedema in axial spondyloarthritis: training and validation using two large phase 3 trial datasetsAmir Jamaludin, Rhydian Windsor, Sarim Ather, et al.
Chinese Medical Journal|September 14, 2020
Secukinumab provided significant and sustained improvement in the signs and symptoms of ankylosing spondylitis: results from the 52-week, Phase III China-centric study, MEASURE 5Feng Huang, Fei Sun, Wei-Guo Wan, et al.
Journal of Medical Radiation Sciences|August 13, 2021
Comprehensive nodal breast VMAT: solving the low-dose wash dilemma using an iterative knowledge-based radiotherapy planning solutionCameron Stanton, Linda J Bell, Andrew Le, et al.
International Journal of Radiation Oncology, Biology, Physics|October 1, 2024
Real-World Implementation of Simulation-Free Radiation Therapy (SFRT-1000): A Propensity Score-Matched Analysis of 1000 Consecutive Palliative Courses Delivered in Routine CareThilo Schuler, Stephanie Roderick, Shelley Wong, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 1, 2024
Effect of Secukinumab Versus Adalimumab Biosimilar on Radiographic Progression in Patients With Radiographic Axial Spondyloarthritis: Results From a Head-to-Head Randomized Phase IIIb StudyXenofon Baraliakos, Mikkel Østergaard, Denis Poddubnyy, et al.
The Journal of Clinical Endocrinology and Metabolism|December 9, 2025
Secukinumab in Moderate-to-Severe Graves' Orbitopathy: A Randomized, Double-Blind, Placebo-Controlled, Multicenter StudyJan Wolf, Katrin Lorenz, Ahmed E Othman, et al.
Journal of Neuropathology and Experimental Neurology|September 22, 2018
A Revised Diagnostic Classification of Canine Glioma: Towards Validation of the Canine Glioma Patient as a Naturally Occurring Preclinical Model for Human GliomaJennifer W Koehler, Andrew D Miller, C Ryan Miller, et al.
Proceedings. Biological Sciences|August 12, 2025
Decision-making preferences for intuition, deliberation, friends or crowds in independent and interdependent societiesIgor Grossmann, Maksim Rudnev, Anna Dorfman, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
The Journal of Rheumatology|March 16, 2021
Secukinumab Efficacy on Enthesitis in Patients With Ankylosing Spondylitis: Pooled Analysis of Four Pivotal Phase III StudiesGeorg Schett, Xenofon Baraliakos, Filip Van den Bosch, et al.
ACR Open Rheumatology|May 1, 2020
Incidence of Uveitis in Secukinumab-treated Patients With Ankylosing Spondylitis: Pooled Data Analysis From Three Phase 3 StudiesAtul A Deodhar, Corine Miceli-Richard, Xenofon Baraliakos, et al.
Rheumatology (Oxford, England)|June 9, 2025
Automated detection of spinal bone marrow oedema in axial spondyloarthritis: training and validation using two large phase 3 trial datasetsAmir Jamaludin, Rhydian Windsor, Sarim Ather, et al.
Chinese Medical Journal|September 14, 2020
Secukinumab provided significant and sustained improvement in the signs and symptoms of ankylosing spondylitis: results from the 52-week, Phase III China-centric study, MEASURE 5Feng Huang, Fei Sun, Wei-Guo Wan, et al.
Journal of Medical Radiation Sciences|August 13, 2021
Comprehensive nodal breast VMAT: solving the low-dose wash dilemma using an iterative knowledge-based radiotherapy planning solutionCameron Stanton, Linda J Bell, Andrew Le, et al.
International Journal of Radiation Oncology, Biology, Physics|October 1, 2024
Real-World Implementation of Simulation-Free Radiation Therapy (SFRT-1000): A Propensity Score-Matched Analysis of 1000 Consecutive Palliative Courses Delivered in Routine CareThilo Schuler, Stephanie Roderick, Shelley Wong, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 1, 2024
Effect of Secukinumab Versus Adalimumab Biosimilar on Radiographic Progression in Patients With Radiographic Axial Spondyloarthritis: Results From a Head-to-Head Randomized Phase IIIb StudyXenofon Baraliakos, Mikkel Østergaard, Denis Poddubnyy, et al.
The Journal of Clinical Endocrinology and Metabolism|December 9, 2025
Secukinumab in Moderate-to-Severe Graves' Orbitopathy: A Randomized, Double-Blind, Placebo-Controlled, Multicenter StudyJan Wolf, Katrin Lorenz, Ahmed E Othman, et al.
Journal of Neuropathology and Experimental Neurology|September 22, 2018
A Revised Diagnostic Classification of Canine Glioma: Towards Validation of the Canine Glioma Patient as a Naturally Occurring Preclinical Model for Human GliomaJennifer W Koehler, Andrew D Miller, C Ryan Miller, et al.
Proceedings. Biological Sciences|August 12, 2025
Decision-making preferences for intuition, deliberation, friends or crowds in independent and interdependent societiesIgor Grossmann, Maksim Rudnev, Anna Dorfman, et al.
Pageof 5